A Nature Communications study has introduced a cutting-edge genetic barcoding approach to monitor how cancer cells dynamically adapt and develop drug resistance over time. By tagging individual tumor cells with unique DNA sequences, researchers can trace subclonal lineage shifts and phenotype changes under therapeutic pressure. This method captures the complex evolutionary landscape of tumors, revealing that resistance mechanisms extend beyond expansion of pre-existing clones, highlighting new avenues for treatment strategies to circumvent or delay resistance.